Food and Drug Administration Drug Safety Podcast
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:03:30
- Mais informações
Informações:
Sinopse
Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions.
